Pharma Focus America
ThermoFisherScientific - Custom and Bulks

LATEST NEWSRead more...

21

Jun 2024

Kanvas Biosciences Launches a Novel Drug Candidate for Its Immuno-oncology Program

Kanvas Biosciences a company specializing in spatial biology has introduced its latest drug candidate KAN within its Immunooncology Program The Kanvas platform uniquely maps interactions between

21

Jun 2024

Spinogenix Receives Approval to Begin Phase 2 Clinical Trial of SPG302 for Alzheimer’s Disease Treatment

Spinogenix Inc has received approval to begin Phase trials of SPG in Australia for treating adults with mildtomoderate Alzheimers disease This clinical study aims to evaluate SPGs safety

21

Jun 2024

C3i Center Inc. Becomes the First CDMO in Canada to Receive Approval for Commercial Production of Cell Therapy Drugs

Ci Center Inc has received regulatory approval from Health Canada in the form of a Drug Establishment License making it the first Contract Development and Manufacturing Organization

20

Jun 2024

Yellowstone Biosciences Begins with £16.5 Million Investment to Create Soluble Bispecific TCR Cancer Treatments

Yellowstone Biosciences a pioneer in developing soluble bispecific Tcell receptor TCRbased therapies targeting human leukocyte antigen HLA Class II in oncology has officially launched today

20

Jun 2024

Aurion Biotech Has Been Granted Breakthrough Therapy Designation and Regenerative Medicine Advanced Therapy Designation for Its Drug Candidate AURN001

Aurion Biotech has announced that the US Food and Drug Administration granted Breakthrough Therapy

19

Jun 2024

Marea Therapeutics Begins Operations with $190 Million to Advance Innovative Cardiometabolic Disease Therapies

Marea Therapeutics a biotechnology company launched by Third Rock Ventures announced today that it has secured million in combined Series A and B financings The Series A round was led by Third Rock

press releasesRead more...

Sarepta Therapeutics Announces Expanded US FDA Approval of ELEVIDYS to Duchenne Muscular Dystrophy Patients Ages 4 and Above

Sarepta Therapeutics Inc the leader in precision genetic medicine for rare diseases today announced US Food and Drug Administration approval of an expansion

API and the University of Alberta Break Ground in Edmonton on Canada’s Largest Manufacturing Facility for Critical Medicines

Construction is set to begin on a crucial pharmaceutical manufacturing facility in the Edmonton Research Park that will provide Canadians with access to a stable supply of highdemand critical drugs at the most difficult of times

Results from XBiotech's randomized, double-blind Phase I/II study suggest potential breakthrough treatment for advanced pancreatic cancer

XBiotech today announced data from its randomized doubleblind placebocontrolled multicenter Phase III trial for the treatment of advanced pancreatic cancer The trial

AbTherx Opens Antibody Discovery Technologies Research Center

AbTherx Inc a biotechnology company with innovative technologies that enable and accelerate antibody discovery today announced the opening of its new antibody discovery technologies research center

25 - 27

Jun 2024

Future Pharma

Boston, MA, USA

25 - 26

Jun 2024

25 - 27

Jun 2024

26 - 26

Jun 2024

26 - 27

Jun 2024

Future Labs

Basel, Switzerland

26 - 27

Jun 2024

08 - 10

Jul 2024
Testing The WorldCelebrating 70 Years of Nalgene
Thermo Fisher Scientific viral vector services (VVS)
Future Labs Live USA 2024
patheon - Mastering API production at every scale
World Orphan Drug Congress Europe 2024

TOP ARTICLES

  • 2

    Challenges and Opportunities in Market Access for New Drugs

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 3

    The Critical Role of Contract Research Organizations in Pharma Development

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 4

    Understanding Over-the-Counter (OTC) Drugs: Trends and Opportunities in Pharma

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 5

    Navigating the Storm: Emerging Challenges in the Pharmaceutical Industry

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

KNOWLEDGE BANK

EDITORIAL SECTION

  • Information Technology

    How AI is Transforming the Pharma Industry

    The global pharmaceutical industry is currently facing many wide ranging challenges including an aging population increased life expectancy a rise in chronic conditions reduced funding for treatments reduced numbers of clinical staff the ever increasing cost of drug development and raw materials and supply chain issues